Transcatheter non-acute retrieval of the tine-based leadless ventricular pacemaker
Europace · 2024
DOI: 10.1093/europace/euae256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, 2024. Verfasst von Moritoshi Funasako und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Na Homolce Hospital, Roentgenova 37/2, 15030 Prague, Czech Republic. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Device Removal, Cardiac Catheterization. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, NHH.
Abstract (Originalsprache)
Aims
We report our single-centre experience of mid-term to long-term retrieval and reimplantation of a tine-based leadless pacemaker [Micra transcatheter pacing system (TPS)]. The TPS is a clinically effective alternative to transvenous single-chamber ventricular pacemakers. Whereas it is currently recommended to abandon the TPS at the end of device life, catheter-based retrieval may be favourable in specific scenarios. Methods and results We report on nine consecutive patients with the implanted TPS who subsequently underwent transcatheter retrieval attempts. The retrieval system consists of the original TPS delivery catheter and an off-the-shelf single-loop 7 mm snare. The procedure was guided by fluoroscopy and intracardiac echocardiography. After an implantation duration of 3.1 ± 2.8 years (range 0.4–9.0), the overall retrieval success rate was 88.9% (8 of 9 patients). The mean procedure time was 89 ± 16 min, and the fluoroscopy time was 18.0 ± 6.6 min. No procedure-related adverse device events occurred. In the one unsuccessful retrieval, intracardiac echocardiography revealed that the TPS was partially embedded in the ventricular tissue surrounding the leadless pacemaker body in the right ventricle. After retrieval, three patients were reimplanted with a new TPS device. All implantations were successful without complications.
Conclusion
A series of transvenous late retrievals of implanted TPS devices demonstrated safety and feasibility, followed by elective replacement with a new leadless pacing device or conventional transvenous pacing system. This provides a viable end-of-life management alternative to simple abandonment of this leadless pacemaker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Na Homolce Hospital, Roentgenova 37/2, 15030 Prague, Czech Republic.
- Medtronic, Minneapolis, MN, USA.
- Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
ORCID-Profile: Moritoshi Funasako, Pavel Hála, Lucie Šedivá, Vivek Y Reddy, Petr Neužil
Förderung
- Ministry of Health
- NHH
Zitieren
APA
Funasako, M., Hála, P., Janotka, M., Šorf, J., Machová, L., Petrů, J., Chovanec, M., Škoda, J., Šedivá, L., Šimon, J., Dujka, L., Reddy, V. Y., & Neužil, P. (2024). Transcatheter non-acute retrieval of the tine-based leadless ventricular pacemaker. Europace. https://doi.org/10.1093/europace/euae256
Vancouver
Funasako M, Hála P, Janotka M, Šorf J, Machová L, Petrů J, et al. Transcatheter non-acute retrieval of the tine-based leadless ventricular pacemaker. Europace. 2024. doi:10.1093/europace/euae256
BibTeX
@article{Funasako2024,
author = {Funasako, Moritoshi and Hála, Pavel and Janotka, Marek and Šorf, Jan and Machová, Lucie and Petrů, Jan and Chovanec, Milan and Škoda, Jan and Šedivá, Lucie and Šimon, Jaroslav and Dujka, Libor and Reddy, Vivek Y and Neužil, Petr},
title = {Transcatheter non-acute retrieval of the tine-based leadless ventricular pacemaker},
journal = {Europace},
year = {2024},
doi = {10.1093/europace/euae256}
}
EUVIMED